Caught on the wrong foot
24/06/20 -"Solvay’s €1.5bn impairment of the back of the current challenging business situation is the price the current management has to pay for the predecessor’s expensive decisions. The ..."
Pages
63
Language
English
Published on
24/06/20
You may also be interested by these reports :
17/08/26
Symrise (ADD; Germany) is the smallest of the four Flavours & Fragrances majors and the one that bought its way to diversification. The shares are up ...
13/08/26
Umicore (Reduce, Belgium) has been a money maker for investors, albeit at a cost to their blood pressure levels. Since we last teased the company ...
12/08/26
Brenntag delivered a strong Q2, with operating EBITDA of €463m, supported by favourable chemical pricing, improved commercial execution and €41m of ...
12/08/26
K+S reported a strong set of numbers for Q2 2026, largely driven by volumes. EBITDA gained significantly from the higher volumes and prices, although ...